|
1
|
Neogenin, a receptor for bone morphogenetic proteins.
|
J Biol Chem
|
2010
|
1.04
|
|
2
|
In vitro generation of a scaffold-free tissue-engineered construct (TEC) derived from human synovial mesenchymal stem cells: biological and mechanical properties and further chondrogenic potential.
|
Tissue Eng Part A
|
2008
|
0.97
|
|
3
|
Distraction osteogenesis for correction of three-dimensional deformities with shortening of lower limbs by Taylor Spatial Frame.
|
Arch Orthop Trauma Surg
|
2008
|
0.91
|
|
4
|
IL-6 negatively regulates osteoblast differentiation through the SHP2/MEK2 and SHP2/Akt2 pathways in vitro.
|
J Bone Miner Metab
|
2014
|
0.90
|
|
5
|
An overgrowth disorder associated with excessive production of cGMP due to a gain-of-function mutation of the natriuretic peptide receptor 2 gene.
|
PLoS One
|
2012
|
0.88
|
|
6
|
PKCα suppresses osteoblastic differentiation.
|
Bone
|
2010
|
0.87
|
|
7
|
Treatment of partial growth arrest using an in vitro-generated scaffold-free tissue-engineered construct derived from rabbit synovial mesenchymal stem cells.
|
J Pediatr Orthop
|
2012
|
0.81
|
|
8
|
Equivalent osteoblastic differentiation function of human mesenchymal stem cells from rheumatoid arthritis in comparison with osteoarthritis.
|
Rheumatology (Oxford)
|
2009
|
0.81
|
|
9
|
Inorganic polyphosphate differentiates human mesenchymal stem cells into osteoblastic cells.
|
J Bone Miner Metab
|
2010
|
0.80
|
|
10
|
Scaffold-free tissue-engineered construct-hydroxyapatite composites generated by an alternate soaking process: potential for repair of bone defects.
|
Tissue Eng Part A
|
2009
|
0.79
|
|
11
|
Spleen tyrosine kinase suppresses osteoblastic differentiation through MAPK and PKCα.
|
Biochem Biophys Res Commun
|
2011
|
0.78
|
|
12
|
Myxoid liposarcoma with adipocytic maturation: detection of TLS/CHOP fusion gene transcript.
|
Diagn Mol Pathol
|
2004
|
0.77
|
|
13
|
A novel anti-rheumatic drug, T-614, stimulates osteoblastic differentiation in vitro and bone morphogenetic protein-2-induced bone formation in vivo.
|
Biochem Biophys Res Commun
|
2002
|
0.76
|
|
14
|
Bruton tyrosine kinase (Btk) suppresses osteoblastic differentiation.
|
J Bone Miner Metab
|
2014
|
0.75
|